Theratechnologies, Inc. (THTX) - Market Valuation

Theratechnologies Inc. (THTX) attracts biochemists by developing therapies for oncology and HIV, while maintaining an ethical environment and a stock option system. This chart illustrates that the asset's market value is 0.16. Theratechnologies Inc. (THTX) is implementing digital control over clinical data by utilizing automation at external plants. The chain is completed by strict adherence to temperature controls during drug transportation to preserve efficacy.

THTX (Theratechnologies) Market Capitalization history from 07/04/2022 to 10/11/2025

Comprehensive metric breakdowns and analytics for Theratechnologies, Inc (THTX)

- current price and projected stock value:

Stock Price Theratechnologies|THTX - Fair Value Consensus

- market capitalization indicators:

Market Valuation Theratechnologies, Inc|THTX - Aggregate Business Value

- business book valuation details:

Accounting Value per Share Theratechnologies|THTX - Accounting Capitalization|Market Value to Book Value Ratio theratech.com|THTX - Total Asset Value of Company

- debt obligations and liquidity statistics:

Total Debt to Capital Theratechnologies Inc.|THTX - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Theratechnologies Inc.|THTX - Company Aggregate Debts|Debt to Book Capitalization Ratio Theratechnologies, Inc|THTX - Company Long-Term Loans and Borrowings|Company Short-Term Debt Theratechnologies|Quick Ratio theratech.com

- net income and valuation multiples indicators:

THTX - Net Profit|Future Profit Theratechnologies Inc.|THTX - Company Value to Net Income|Forward P/E Multiple Theratechnologies Inc|THTX - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Theratechnologies, Inc|THTX - Operating profit before deduction of amortization|Earnings per share for the last twelve months Theratechnologies|THTX - Net earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months theratech.com|THTX - Earnings growth in current year|Net earnings per share growth forecast for next year Theratechnologies Inc.

- sales and revenue indicators:

THTX - Company Sales Volume|Projected Sales Volume Theratechnologies|THTX - Price to Sales|Forward Price-to-Revenue Multiple Theratechnologies, Inc

Fundamental company analysis:THTX (Theratechnologies)

Product sample of Theratechnologies, Inc

Theratechnologies Inc. minimizes capital expenditures by outsourcing drug synthesis and testing to external contractors. Market capitalization reflects the aggregate value of all shares, defining the scale of the business through market demand. This indicator allows for a comparison of the company's actual value against stock index requirements. Volatility analysis helps assess the risk of capital loss during asset revaluation. The issuer's current market valuation objectifies these market fluctuations.

Key competitors